Listed

Maravai Lifesciences Holdings, Inc.

MRVINasdaqCIK 1823239HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$51.4m, Q2 FY2026
Operating income−$15.1m, Q2 FY2026
Net income−$12.4m, Q2 FY2026
Maravai Lifesciences Holdings, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m66.9Revenue, Q3 FY2023, three months to 2023-09-30$66.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-12, accession 0001823239-24-000118.Report this figure74.1Revenue, Q4 FY2023, three months to 2023-12-31$74.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure64.2Revenue, Q1 FY2024, three months to 2024-03-31$64.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-12, accession 0001823239-25-000063.Report this figure69.4Revenue, Q2 FY2024, three months to 2024-06-30$69.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-11, accession 0001823239-25-000107.Report this figure69.0Revenue, Q3 FY2024, three months to 2024-09-30$69.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure56.6Revenue, Q4 FY2024, three months to 2024-12-31$56.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure46.9Revenue, Q1 FY2025, three months to 2025-03-31$46.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure47.4Revenue, Q2 FY2025, three months to 2025-06-30$47.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure41.6Revenue, Q3 FY2025, three months to 2025-09-30$41.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure49.9Revenue, Q4 FY2025, three months to 2025-12-31$49.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure65.8Revenue, Q1 FY2026, three months to 2026-03-31$65.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure51.4Revenue, Q2 FY2026, three months to 2026-06-30$51.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure
Cost of revenue$m36.7Cost of revenue, Q3 FY2023, three months to 2023-09-30$36.7m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-12, accession 0001823239-24-000118.Report this figure35.1Cost of revenue, Q4 FY2023, three months to 2023-12-31$35.1m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure38.3Cost of revenue, Q1 FY2024, three months to 2024-03-31$38.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-12, accession 0001823239-25-000063.Report this figure38.6Cost of revenue, Q2 FY2024, three months to 2024-06-30$38.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-11, accession 0001823239-25-000107.Report this figure36.8Cost of revenue, Q3 FY2024, three months to 2024-09-30$36.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure37.2Cost of revenue, Q4 FY2024, three months to 2024-12-31$37.2m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure39.1Cost of revenue, Q1 FY2025, three months to 2025-03-31$39.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure39.6Cost of revenue, Q2 FY2025, three months to 2025-06-30$39.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure36.0Cost of revenue, Q3 FY2025, three months to 2025-09-30$36.0m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure37.0Cost of revenue, Q4 FY2025, three months to 2025-12-31$37.0m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure32.1Cost of revenue, Q1 FY2026, three months to 2026-03-31$32.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure30.8Cost of revenue, Q2 FY2026, three months to 2026-06-30$30.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure
Gross profit$mnot reportednot reportednot reportednot reported32.2Gross profit, Q3 FY2024, three months to 2024-09-30$32.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure19.4Gross profit, Q4 FY2024, three months to 2024-12-31$19.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure7.7Gross profit, Q1 FY2025, three months to 2025-03-31$7.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure7.8Gross profit, Q2 FY2025, three months to 2025-06-30$7.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure5.7Gross profit, Q3 FY2025, three months to 2025-09-30$5.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure12.8Gross profit, Q4 FY2025, three months to 2025-12-31$12.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure33.7Gross profit, Q1 FY2026, three months to 2026-03-31$33.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure20.7Gross profit, Q2 FY2026, three months to 2026-06-30$20.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure
Research and development$m4.3Research and development, Q3 FY2023, three months to 2023-09-30$4.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001823239-24-000118.Report this figure4.6Research and development, Q4 FY2023, three months to 2023-12-31$4.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure5.0Research and development, Q1 FY2024, three months to 2024-03-31$5.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001823239-25-000063.Report this figure4.9Research and development, Q2 FY2024, three months to 2024-06-30$4.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-11, accession 0001823239-25-000107.Report this figure4.7Research and development, Q3 FY2024, three months to 2024-09-30$4.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure4.6Research and development, Q4 FY2024, three months to 2024-12-31$4.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure4.9Research and development, Q1 FY2025, three months to 2025-03-31$4.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure4.9Research and development, Q2 FY2025, three months to 2025-06-30$4.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure3.8Research and development, Q3 FY2025, three months to 2025-09-30$3.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure3.8Research and development, Q4 FY2025, three months to 2025-12-31$3.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure3.9Research and development, Q1 FY2026, three months to 2026-03-31$3.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure3.7Research and development, Q2 FY2026, three months to 2026-06-30$3.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure
Selling, general and administrative$m38.9Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$38.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-12, accession 0001823239-24-000118.Report this figure38.5Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$38.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure40.9Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$40.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-12, accession 0001823239-25-000063.Report this figure40.6Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$40.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-11, accession 0001823239-25-000107.Report this figure39.1Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$39.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure41.2Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$41.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure39.6Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$39.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure38.7Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$38.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure35.4Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$35.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure31.6Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$31.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure29.1Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$29.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure32.1Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$32.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure
Operating income$m(15.4)Operating income, Q3 FY2023, three months to 2023-09-30−$15.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001823239-24-000118.Report this figure(7.2)Operating income, Q4 FY2023, three months to 2023-12-31−$7.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(18.9)Operating income, Q1 FY2024, three months to 2024-03-31−$18.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0001823239-25-000063.Report this figure(13.4)Operating income, Q2 FY2024, three months to 2024-06-30−$13.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-11, accession 0001823239-25-000107.Report this figure(166)Operating income, Q3 FY2024, three months to 2024-09-30−$165.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure(37.7)Operating income, Q4 FY2024, three months to 2024-12-31−$37.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(49.2)Operating income, Q1 FY2025, three months to 2025-03-31−$49.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure(66.3)Operating income, Q2 FY2025, three months to 2025-06-30−$66.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure(41.0)Operating income, Q3 FY2025, three months to 2025-09-30−$41.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure(58.8)Operating income, Q4 FY2025, three months to 2025-12-31−$58.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(2.2)Operating income, Q1 FY2026, three months to 2026-03-31−$2.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure(15.1)Operating income, Q2 FY2026, three months to 2026-06-30−$15.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure
Interest expense$m11.6Interest expense, Q3 FY2023, three months to 2023-09-30$11.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-12, accession 0001823239-24-000118.Report this figure15.4Interest expense, Q4 FY2023, three months to 2023-12-31$15.4m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-29, accession 0001823239-24-000032. Derived: 12-month figure less the 9-month figure.Report this figure10.9Interest expense, Q1 FY2024, three months to 2024-03-31$10.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-09, accession 0001823239-24-000060.Report this figure11.9Interest expense, Q2 FY2024, three months to 2024-06-30$11.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-08, accession 0001823239-24-000095.Report this figure13.6Interest expense, Q3 FY2024, three months to 2024-09-30$13.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-12, accession 0001823239-24-000118.Report this figure11.3Interest expense, Q4 FY2024, three months to 2024-12-31$11.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure6.8Interest expense, Q1 FY2025, three months to 2025-03-31$6.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure6.8Interest expense, Q2 FY2025, three months to 2025-06-30$6.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure6.8Interest expense, Q3 FY2025, three months to 2025-09-30$6.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure6.6Interest expense, Q4 FY2025, three months to 2025-12-31$6.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure5.7Interest expense, Q1 FY2026, three months to 2026-03-31$5.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure4.8Interest expense, Q2 FY2026, three months to 2026-06-30$4.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure
Income tax$m(5.5)Income tax, Q3 FY2023, three months to 2023-09-30−$5.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0001823239-24-000118.Report this figure766Income tax, Q4 FY2023, three months to 2023-12-31$766.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure0.3Income tax, Q1 FY2024, three months to 2024-03-31$271.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-12, accession 0001823239-25-000063.Report this figure(2.4)Income tax, Q2 FY2024, three months to 2024-06-30−$2.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-11, accession 0001823239-25-000107.Report this figure0.3Income tax, Q3 FY2024, three months to 2024-09-30$311.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure(0.0)Income tax, Q4 FY2024, three months to 2024-12-31−$7.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure0.2Income tax, Q1 FY2025, three months to 2025-03-31$162.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure(4.3)Income tax, Q2 FY2025, three months to 2025-06-30−$4.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure(0.1)Income tax, Q3 FY2025, three months to 2025-09-30−$92.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$6.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(0.2)Income tax, Q1 FY2026, three months to 2026-03-31−$151.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure(0.2)Income tax, Q2 FY2026, three months to 2026-06-30−$171.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure
Net income$m(6.5)Net income, Q3 FY2023, three months to 2023-09-30−$6.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001823239-24-000118.Report this figure(106)Net income, Q4 FY2023, three months to 2023-12-31−$106.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(12.1)Net income, Q1 FY2024, three months to 2024-03-31−$12.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-12, accession 0001823239-25-000063.Report this figure(9.8)Net income, Q2 FY2024, three months to 2024-06-30−$9.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-11, accession 0001823239-25-000107.Report this figure(97.1)Net income, Q3 FY2024, three months to 2024-09-30−$97.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure(25.9)Net income, Q4 FY2024, three months to 2024-12-31−$25.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(29.9)Net income, Q1 FY2025, three months to 2025-03-31−$29.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure(39.6)Net income, Q2 FY2025, three months to 2025-06-30−$39.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure(25.6)Net income, Q3 FY2025, three months to 2025-09-30−$25.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure(35.7)Net income, Q4 FY2025, three months to 2025-12-31−$35.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(3.7)Net income, Q1 FY2026, three months to 2026-03-31−$3.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure(12.4)Net income, Q2 FY2026, three months to 2026-06-30−$12.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure
Diluted EPS$ per share(0.05)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001823239-24-000118.Report this figurenot reported(0.09)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0001823239-25-000063.Report this figure(0.07)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-11, accession 0001823239-25-000107.Report this figure(0.68)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.68 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figurenot reported(0.21)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure(0.27)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure(0.18)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figurenot reported(0.02)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure(0.08)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure
Basic EPS$ per share(0.05)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001823239-24-000118.Report this figurenot reported(0.09)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0001823239-25-000063.Report this figure(0.07)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-11, accession 0001823239-25-000107.Report this figure(0.68)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.68 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figurenot reported(0.21)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure(0.27)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure(0.18)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figurenot reported(0.02)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure(0.08)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure

Balance sheet

Cash and equivalents$70.1m, Q2 FY2026
Long-term debt$146.0m, Q2 FY2026
Shareholders' equity$204.6m, Q2 FY2026
Maravai Lifesciences Holdings, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m580Cash and equivalents, Q3 FY2023, at 2023-09-30$579.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-08, accession 0001823239-23-000089.Report this figure575Cash and equivalents, FY2023, at 2023-12-31$575.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure562Cash and equivalents, Q1 FY2024, at 2024-03-31$561.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0001823239-24-000060.Report this figure573Cash and equivalents, Q2 FY2024, at 2024-06-30$573.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure578Cash and equivalents, Q3 FY2024, at 2024-09-30$578.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure322Cash and equivalents, FY2024, at 2024-12-31$322.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001823239-26-000011.Report this figure285Cash and equivalents, Q1 FY2025, at 2025-03-31$285.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0001823239-25-000063.Report this figure270Cash and equivalents, Q2 FY2025, at 2025-06-30$269.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure244Cash and equivalents, Q3 FY2025, at 2025-09-30$243.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure217Cash and equivalents, FY2025, at 2025-12-31$216.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure166Cash and equivalents, Q1 FY2026, at 2026-03-31$165.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure70.1Cash and equivalents, Q2 FY2026, at 2026-06-30$70.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure
Current assets$m701Current assets, Q3 FY2023, at 2023-09-30$700.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0001823239-23-000089.Report this figure700Current assets, FY2023, at 2023-12-31$699.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure668Current assets, Q1 FY2024, at 2024-03-31$667.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001823239-24-000060.Report this figure682Current assets, Q2 FY2024, at 2024-06-30$681.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure679Current assets, Q3 FY2024, at 2024-09-30$679.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure429Current assets, FY2024, at 2024-12-31$429.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001823239-26-000011.Report this figure376Current assets, Q1 FY2025, at 2025-03-31$376.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0001823239-25-000063.Report this figure360Current assets, Q2 FY2025, at 2025-06-30$359.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-11, accession 0001823239-25-000107.Report this figure326Current assets, Q3 FY2025, at 2025-09-30$325.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure296Current assets, FY2025, at 2025-12-31$296.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure252Current assets, Q1 FY2026, at 2026-03-31$251.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure156Current assets, Q2 FY2026, at 2026-06-30$155.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure
Total assets$m2,268Total assets, Q3 FY2023, at 2023-09-30$2.27bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0001823239-23-000089.Report this figure1,487Total assets, FY2023, at 2023-12-31$1.49bn. XBRL concept us-gaap:Assets. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure1,445Total assets, Q1 FY2024, at 2024-03-31$1.44bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001823239-24-000060.Report this figure1,444Total assets, Q2 FY2024, at 2024-06-30$1.44bn. XBRL concept us-gaap:Assets. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure1,278Total assets, Q3 FY2024, at 2024-09-30$1.28bn. XBRL concept us-gaap:Assets. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure1,008Total assets, FY2024, at 2024-12-31$1.01bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001823239-26-000011.Report this figure960Total assets, Q1 FY2025, at 2025-03-31$959.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0001823239-25-000063.Report this figure897Total assets, Q2 FY2025, at 2025-06-30$897.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-11, accession 0001823239-25-000107.Report this figure849Total assets, Q3 FY2025, at 2025-09-30$849.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure771Total assets, FY2025, at 2025-12-31$770.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure713Total assets, Q1 FY2026, at 2026-03-31$713.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure604Total assets, Q2 FY2026, at 2026-06-30$603.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure
Current liabilities$m78.3Current liabilities, Q3 FY2023, at 2023-09-30$78.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0001823239-23-000089.Report this figure87.5Current liabilities, FY2023, at 2023-12-31$87.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure59.0Current liabilities, Q1 FY2024, at 2024-03-31$59.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0001823239-24-000060.Report this figure68.6Current liabilities, Q2 FY2024, at 2024-06-30$68.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure63.7Current liabilities, Q3 FY2024, at 2024-09-30$63.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure57.0Current liabilities, FY2024, at 2024-12-31$57.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001823239-26-000011.Report this figure63.2Current liabilities, Q1 FY2025, at 2025-03-31$63.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0001823239-25-000063.Report this figure69.7Current liabilities, Q2 FY2025, at 2025-06-30$69.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-11, accession 0001823239-25-000107.Report this figure61.6Current liabilities, Q3 FY2025, at 2025-09-30$61.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure44.9Current liabilities, FY2025, at 2025-12-31$44.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure42.6Current liabilities, Q1 FY2026, at 2026-03-31$42.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure38.4Current liabilities, Q2 FY2026, at 2026-06-30$38.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure
Total liabilities$m1,375Total liabilities, Q3 FY2023, at 2023-09-30$1.38bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0001823239-23-000089.Report this figure698Total liabilities, FY2023, at 2023-12-31$697.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure667Total liabilities, Q1 FY2024, at 2024-03-31$667.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001823239-24-000060.Report this figure671Total liabilities, Q2 FY2024, at 2024-06-30$671.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure666Total liabilities, Q3 FY2024, at 2024-09-30$665.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure431Total liabilities, FY2024, at 2024-12-31$431.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001823239-26-000011.Report this figure429Total liabilities, Q1 FY2025, at 2025-03-31$429.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0001823239-25-000063.Report this figure429Total liabilities, Q2 FY2025, at 2025-06-30$429.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-11, accession 0001823239-25-000107.Report this figure417Total liabilities, Q3 FY2025, at 2025-09-30$417.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure398Total liabilities, FY2025, at 2025-12-31$397.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure344Total liabilities, Q1 FY2026, at 2026-03-31$344.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure248Total liabilities, Q2 FY2026, at 2026-06-30$248.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure
Long-term debt$m520Long-term debt, Q3 FY2023, at 2023-09-30$519.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-08, accession 0001823239-23-000089.Report this figure519Long-term debt, FY2023, at 2023-12-31$518.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure518Long-term debt, Q1 FY2024, at 2024-03-31$517.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-09, accession 0001823239-24-000060.Report this figure517Long-term debt, Q2 FY2024, at 2024-06-30$517.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure516Long-term debt, Q3 FY2024, at 2024-09-30$516.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure290Long-term debt, FY2024, at 2024-12-31$290.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-26, accession 0001823239-26-000011.Report this figure289Long-term debt, Q1 FY2025, at 2025-03-31$289.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-12, accession 0001823239-25-000063.Report this figure288Long-term debt, Q2 FY2025, at 2025-06-30$288.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-11, accession 0001823239-25-000107.Report this figure287Long-term debt, Q3 FY2025, at 2025-09-30$287.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure286Long-term debt, FY2025, at 2025-12-31$286.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure236Long-term debt, Q1 FY2026, at 2026-03-31$235.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure146Long-term debt, Q2 FY2026, at 2026-06-30$146.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure
Current portion of debt$m5.4Current portion of debt, Q3 FY2023, at 2023-09-30$5.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-08, accession 0001823239-23-000089.Report this figure5.4Current portion of debt, FY2023, at 2023-12-31$5.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure5.4Current portion of debt, Q1 FY2024, at 2024-03-31$5.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-09, accession 0001823239-24-000060.Report this figure5.4Current portion of debt, Q2 FY2024, at 2024-06-30$5.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure5.4Current portion of debt, Q3 FY2024, at 2024-09-30$5.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure5.4Current portion of debt, FY2024, at 2024-12-31$5.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-02-26, accession 0001823239-26-000011.Report this figure5.4Current portion of debt, Q1 FY2025, at 2025-03-31$5.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-12, accession 0001823239-25-000063.Report this figure5.4Current portion of debt, Q2 FY2025, at 2025-06-30$5.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-11, accession 0001823239-25-000107.Report this figure5.4Current portion of debt, Q3 FY2025, at 2025-09-30$5.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure5.4Current portion of debt, FY2025, at 2025-12-31$5.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure5.4Current portion of debt, Q1 FY2026, at 2026-03-31$5.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure1.1Current portion of debt, Q2 FY2026, at 2026-06-30$1.1m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure
Shareholders' equity$m519Shareholders' equity, Q3 FY2023, at 2023-09-30$519.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-08, accession 0001823239-23-000089.Report this figure417Shareholders' equity, FY2023, at 2023-12-31$416.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure411Shareholders' equity, Q1 FY2024, at 2024-03-31$410.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-09, accession 0001823239-24-000060.Report this figure435Shareholders' equity, Q2 FY2024, at 2024-06-30$434.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure345Shareholders' equity, Q3 FY2024, at 2024-09-30$344.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-03-18, accession 0001823239-25-000034.Report this figure325Shareholders' equity, FY2024, at 2024-12-31$325.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001823239-26-000011.Report this figure301Shareholders' equity, Q1 FY2025, at 2025-03-31$300.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-12, accession 0001823239-25-000063.Report this figure266Shareholders' equity, Q2 FY2025, at 2025-06-30$265.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-11, accession 0001823239-25-000107.Report this figure245Shareholders' equity, Q3 FY2025, at 2025-09-30$245.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure212Shareholders' equity, FY2025, at 2025-12-31$212.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure212Shareholders' equity, Q1 FY2026, at 2026-03-31$211.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure205Shareholders' equity, Q2 FY2026, at 2026-06-30$204.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure

Cash flow

Operating cash flow$4.0m, Q2 FY2026
Capital expenditure$370.0k, Q2 FY2026
Maravai Lifesciences Holdings, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m14.2Operating cash flow, Q3 FY2023, three months to 2023-09-30$14.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001823239-24-000118. Derived: 9-month figure less the 6-month figure.Report this figure7.8Operating cash flow, Q4 FY2023, three months to 2023-12-31$7.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(8.5)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$8.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001823239-25-000063.Report this figure17.4Operating cash flow, Q2 FY2024, three months to 2024-06-30$17.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-11, accession 0001823239-25-000107. Derived: 6-month figure less the 3-month figure.Report this figure13.1Operating cash flow, Q3 FY2024, three months to 2024-09-30$13.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001823239-25-000120. Derived: 9-month figure less the 6-month figure.Report this figure(14.6)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$14.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(9.4)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$9.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure(10.3)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$10.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001823239-26-000059. Derived: 6-month figure less the 3-month figure.Report this figure(15.2)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$15.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001823239-25-000120. Derived: 9-month figure less the 6-month figure.Report this figure(22.8)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$22.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure8.7Operating cash flow, Q1 FY2026, three months to 2026-03-31$8.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure4.0Operating cash flow, Q2 FY2026, three months to 2026-06-30$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001823239-26-000059. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m15.8Capital expenditure, Q3 FY2023, three months to 2023-09-30$15.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001823239-24-000118. Derived: 9-month figure less the 6-month figure.Report this figure16.8Capital expenditure, Q4 FY2023, three months to 2023-12-31$16.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure5.7Capital expenditure, Q1 FY2024, three months to 2024-03-31$5.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-12, accession 0001823239-25-000063.Report this figure9.6Capital expenditure, Q2 FY2024, three months to 2024-06-30$9.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-11, accession 0001823239-25-000107. Derived: 6-month figure less the 3-month figure.Report this figure8.6Capital expenditure, Q3 FY2024, three months to 2024-09-30$8.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-07, accession 0001823239-25-000120. Derived: 9-month figure less the 6-month figure.Report this figure5.8Capital expenditure, Q4 FY2024, three months to 2024-12-31$5.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure4.5Capital expenditure, Q1 FY2025, three months to 2025-03-31$4.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure2.9Capital expenditure, Q2 FY2025, three months to 2025-06-30$2.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-07, accession 0001823239-26-000059. Derived: 6-month figure less the 3-month figure.Report this figure3.7Capital expenditure, Q3 FY2025, three months to 2025-09-30$3.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-07, accession 0001823239-25-000120. Derived: 9-month figure less the 6-month figure.Report this figure2.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$2.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001823239-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure4.4Capital expenditure, Q1 FY2026, three months to 2026-03-31$4.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure0.4Capital expenditure, Q2 FY2026, three months to 2026-06-30$370.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-07, accession 0001823239-26-000059. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)148.00m, Q2 FY2026
Maravai Lifesciences Holdings, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares132Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30131,651,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0001823239-23-000089.Report this figure132Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31131,739,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0001823239-24-000060.Report this figure132Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30131,864,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001823239-24-000095.Report this figure132Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30131,930,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001823239-24-000118.Report this figure132Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31132,333,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0001823239-25-000063.Report this figure136Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30135,842,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-11, accession 0001823239-25-000107.Report this figure142Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30141,555,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure143Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31143,425,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure144Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30144,236,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure145Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30144,683,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001823239-25-000120.Report this figure146Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31146,426,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-08, accession 0001823239-26-000024.Report this figure148Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30147,996,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-07, accession 0001823239-26-000059.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.